{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:11:40Z","timestamp":1787026300323,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coxsackievirus A6 (CVA6) has emerged as a major etiological agent of hand, foot, and mouth disease (HFMD), yet no commercial vaccine is available against CVA6. CVA6 exhibits poor adaptability to Vero cells, a WHO-approved substrate for human vaccine production, and the mechanisms underlying its infectivity and pathogenesis remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A Vero cell-adapted CVA6 strain was generated through serial passaging\n                      <jats:italic>in vitro<\/jats:italic>\n                      . Two recombinant viruses derived from the earlier and later generations, corresponding to passage 10 and passage 45, were generated and designated rV10 and rV45, respectively. Their phenotypic characteristics, including viral growth kinetics, cytopathic effects, receptor interaction, entry and release efficiency,\n                      <jats:italic>in vivo<\/jats:italic>\n                      pathogenicity, immunogenicity, and host transcriptomic responses, were systematically compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with rV10, rV45 exhibited a pronounced cytolytic phenotype, accompanied by higher viral titers, increased efficiency of viral entry and egress, and enhanced interaction with the receptor KRM1. Notably, rV45 was markedly attenuated in mice while retaining immunogenicity comparable to that of rV10. Comparative sequence analysis revealed ten amino acid substitutions in the structural protein VP1 and one in the non-structural protein 3A between rV10 and rV45. Transcriptome profiling revealed that rV45, but not rV10, preferentially activated several signaling pathways including MAPK, TNF, IL-17, and apoptosis. Further validation demonstrated that rV45 infection triggered caspase-3 cleavage and apoptosis, which facilitated viral proliferation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serial passaging of CVA6 in Vero cells drives coordinated molecular and phenotypic adaptation, predominantly mediated by VP1 mutations that enhance receptor KRM1 utilization and apoptosis-associated viral replication. This study provides novel insights into infectivity and pathogenesis of CVA6 and establish a potential foundation for development of attenuated vaccines against CVA6.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1810260","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:07Z","timestamp":1777354627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Serial passaging in vitro generates a Vero cell-adapted coxsackievirus A6 strain with distinct phenotypic characteristics"],"prefix":"10.3389","volume":"16","author":[{"given":"Sijin","family":"Xia","sequence":"first","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongyu","family":"Shu","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Sun","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wu","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Du","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Shen","sequence":"additional","affiliation":[{"name":"Wuhan Institute of Biological Products Co., Ltd.","place":["Wuhan, China"]},{"name":"National Engineering Technology Research Center for Combined Vaccines","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10384","DOI":"10.1128\/jvi.01083-09","article-title":"Passage of dengue virus type 4 vaccine candidates in fetal rhesus lung cells selects heparin-sensitive variants that result in loss of infectivity and immunogenicity in rhesus macaques","volume":"83","author":"A\u00f1ez","year":"2009","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/22221751.2021.1906754","article-title":"Viral determinants that drive Enterovirus-A71 fitness and virulence","volume":"10","author":"Ang","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"Barrett","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13081","DOI":"10.1073\/pnas.1401437111","article-title":"Nonlytic viral spread enhanced by autophagy components","volume":"111","author":"Bird","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s42003-022-03863-2","article-title":"Cryo-electron microscopy and image classification reveal the existence and structure of the coxsackievirus A6 virion","volume":"5","author":"B\u00fcttner","year":"2022","journal-title":"Commun. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1038\/s41467-023-43029-0","article-title":"A tradeoff between enterovirus A71 particle stability and cell entry","volume":"14","author":"Catching","year":"2023","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/13550280490521032","article-title":"Diverse apoptotic pathways in enterovirus 71-infected cells","volume":"10","author":"Chang","year":"2004","journal-title":"J. Neurovirol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29316","article-title":"Emerging concerns of atypical hand foot and mouth disease caused by recombinant Coxsackievirus A6 variants in Henan, China","volume":"95","author":"Chen","year":"2023","journal-title":"J. Med. Virol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2196\/59604","article-title":"Molecular evolutionary dynamics of coxsackievirus a6 causing hand, foot, and mouth disease from 2021 to 2023 in China: genomic epidemiology study","volume":"10","author":"Chen","year":"2024","journal-title":"JMIR Public Health Surveill."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.21037\/tp-22-352","article-title":"Clinical characteristics of 68 children with atypical hand, foot, and mouth disease caused by coxsackievirus A6: a single-center retrospective analysis","volume":"11","author":"Cheng","year":"2022","journal-title":"Transl. Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1021\/bi6024758","article-title":"Membrane topography of the hydrophobic anchor sequence of poliovirus 3A and 3AB proteins and the functional effect of 3A\/3AB membrane association upon RNA replication","volume":"46","author":"Fujita","year":"2007","journal-title":"Biochemistry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41541-025-01115-y","article-title":"Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens","volume":"10","author":"Hu","year":"2025","journal-title":"NPJ Vaccines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87993","article-title":"SIRT-1 is required for release of enveloped enteroviruses","volume":"12","author":"Jassey","year":"2023","journal-title":"Elife"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13111020","article-title":"Coxsackievirus A6 U.K. genetic and clinical epidemiology pre- and post-SARS-CoV-2 emergence","volume":"13","author":"Joyce","year":"2024","journal-title":"Pathogens"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104307","article-title":"Atypical hand-foot-mouth disease in Bel\u00e9m, Amazon region, northern Brazil, with detection of coxsackievirus A6","volume":"126","author":"Justino","year":"2020","journal-title":"J. Clin. Virol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005033","article-title":"The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a cynomolgus monkey model","volume":"11","author":"Kataoka","year":"2015","journal-title":"PloS Pathog."},{"key":"B18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41467-025-67666-9","article-title":"Molecular mechanisms of receptor recognition and antibody neutralization of coxsackievirus A6","volume":"17","author":"Ke","year":"2025","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/291547a0","article-title":"Primary structure, gene organization and polypeptide expression of poliovirus RNA","volume":"291","author":"Kitamura","year":"1981","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00681-18","article-title":"Amino acid variation at VP1\u2013145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice","volume":"92","author":"Kobayashi","year":"2018","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111174","article-title":"Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"Liu","year":"2016","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.46234\/ccdcw2020.044","article-title":"Pathogen spectrum of hand, foot, and mouth disease based on laboratory surveillance - Chin","volume":"2","author":"Liu","year":"2020","journal-title":"China CDC. Wkly."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101603","article-title":"Epidemiology of hand, foot, and mouth disease outbreaks before and during availability of EV-A71 vaccine in China\u2019s mainland: analysis of outbreak surveillance data from 2011 to 2023","volume":"59","author":"Liu","year":"2025","journal-title":"Lancet Reg. Health West. Pac."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.700191","article-title":"Characterization of coxsackievirus A6 strains isolated from children with hand, foot, and mouth disease","volume":"16","author":"Liu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cell.2006.02.007","article-title":"Virus entry: open sesame","volume":"124","author":"Marsh","year":"2006","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"20909","DOI":"10.1038\/s41598-020-77768-7","article-title":"Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China","volume":"10","author":"Meng","year":"2020","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01055-21","article-title":"A novel attenuated enterovirus A71 mutant with VP1-V238A,K244R exhibits reduced efficiency of cell entry\/exit and augmented binding affinity to sulfated glycans","volume":"95","author":"Meng","year":"2021","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003511","article-title":"Enterovirus 71 binding to PSGL-1 on leukocytes: VP1\u2013145 acts as a molecular switch to control receptor interaction","volume":"9","author":"Nishimura","year":"2013","journal-title":"PloS Pathog."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012022","article-title":"Enterovirus A71 does not meet the uncoating receptor SCARB2 at the cell surface","volume":"20","author":"Nishimura","year":"2024","journal-title":"PloS Pathog."},{"key":"B31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat. Med."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/v15102114","article-title":"Identification of critical amino acids of coxsackievirus A10 associated with cell tropism and viral RNA release during uncoating","volume":"15","author":"Pei","year":"2023","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003046","article-title":"Intracellular vesicle acidification promotes maturation of infectious poliovirus particles","volume":"8","author":"Richards","year":"2012","journal-title":"PloS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/s1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00817","article-title":"Caspase-3 inhibition attenuates the cytopathic effects of EV71 infection","volume":"9","author":"Song","year":"2018","journal-title":"Front. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veaa048","article-title":"Genetic recombination in fast-spreading coxsackievirus A6 variants: a potential role in evolution and pathogenicity","volume":"6","author":"Song","year":"2020","journal-title":"Virus Evol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.chom.2018.03.019","article-title":"KREMEN1 is a host entry receptor for a major group of enteroviruses","volume":"23","author":"Staring","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1128\/jvi.74.19.8953-8965.2000","article-title":"Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles","volume":"74","author":"Suhy","year":"2000","journal-title":"J. Virol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28454","article-title":"Local immune dysregulation and subsequent inflammatory response contribute to pulmonary edema caused by Enterovirus infection in mice","volume":"95","author":"Sun","year":"2023","journal-title":"J. Med. Virol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00128-25","article-title":"A single amino acid mutation in VP1 of coxsackievirus A6 determining efficiency of VP0 cleavage and proliferation","volume":"99","author":"Sun","year":"2025","journal-title":"J. Virol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.98441","article-title":"Virus adaptation to heparan sulfate comes with capsid stability tradeoff","volume":"13","author":"Tee","year":"2024","journal-title":"Elife"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007863","article-title":"Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice","volume":"15","author":"Tee","year":"2019","journal-title":"PloS Pathog."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/srep36983","article-title":"Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway","volume":"6","author":"Too","year":"2016","journal-title":"Sci. Rep."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007190","article-title":"A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism","volume":"14","author":"Tseligka","year":"2018","journal-title":"PloS Pathog."},{"key":"B45","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.micinf.2011.04.004","article-title":"A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice","volume":"13","author":"Wang","year":"2011","journal-title":"Microbes Infect."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2337665","article-title":"Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles","volume":"13","author":"Wang","year":"2024","journal-title":"Emerg. Microbes Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2217\/fmb-2019-0127","article-title":"Multifunctionality of structural proteins in the enterovirus life cycle","volume":"14","author":"Wen","year":"2019","journal-title":"Future Microbiol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112389","article-title":"Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice","volume":"42","author":"Weng","year":"2023","journal-title":"Cell Rep."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/srep12973","article-title":"A broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of enterovirus 71","volume":"5","author":"Xu","year":"2015","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1080\/22221751.2020.1823889","article-title":"Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys","volume":"9","author":"Yang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1099\/jgv.0.000911","article-title":"ICTV virus taxonomy profile: Picornaviridae","volume":"98","author":"Zell","year":"2017","journal-title":"J. Gen. Virol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01655-24","article-title":"Novel virulence determinants in VP1 regulate the assembly of enterovirus-A71","volume":"98","author":"Zhang","year":"2024","journal-title":"J. Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/22221751.2021.2016354","article-title":"Sequence duplication in 3\u2019 UTR modulates virus replication and virulence of Japanese encephalitis virus","volume":"11","author":"Zhang","year":"2022","journal-title":"Emerg. Microbes Infect."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1810260\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:37:08Z","timestamp":1777354628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1810260\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":54,"alternative-id":["10.3389\/fcimb.2026.1810260"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1810260","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1810260"}}